The Annual Meeting of the American College of Rheumatologists was held virtually November 3-10, 2021. Vanderbilt University Medical Center presenters included:
Jason Springer, M.D.
Pharmacological Response of Rituximab Based on Dose Intensity in Maintenance; Hot Topics in Research & New ACR/VF Guidelines – Part 2: Treatment of Large-vessel Vasculitis
A Patient-Powered Research Network for Vasculitis
Erin Wilfong, M.D.
High-Dimensional Analysis Reveals Abnormal B Cell Subsets Associated with Specific Changes to Circulating T and Myeloid Cell Populations in Patients with Idiopathic Inflammatory Myopathies; Pathophysiology of the Antifibrotic Pathway & Rationale for Drug Class in CTD-ILD; Rheumatology Intensivists: Managing Critical Illness in Autoimmune Disease
Improving Diagnoses of Lung-predominant Autoimmune Disease
Jeffrey Rathmell, Ph.D.
Metabolic Regulation of Immune Function; Overview of Immunometabolism
Deepening Understanding of Immune Disorders
April Barnado, M.D.
Increased Adverse Maternal Postpartum Outcomes in Systemic Lupus Erythematosus Pregnancies Compared to Controls; Tuesday, Class V Systemic Lupus Erythematosus Nephritis Patients Are Undertreated and Face Similar Adverse Renal Outcomes as Class III/IV Patients
Gaps in Lupus Management for Pregnant Women
Adverse Pregnancy Outcomes in Lupus Patients
First-time PheWAS Study Shows Men at Greater AFib Risk
Douglas Johnson, M.D.
Outcomes and Disease Characteristics in Patients with Rheumatoid Arthritis Treated with Immune Checkpoint Inhibitors for Malignancy
A Preclinical Model of Cancer Immunotherapy Associated-Myocarditis
Tackling Complications of Immune-Based Therapies
Evaluating Long-term Outcomes for Metastatic Melanoma Therapies
Elizabeth Phillips, M.D.
Pediatrics – Still’s Disease, Lung Complications & Drug Hypersensitivity
